Officials in South Africa recently halted the rollout of AstraZeneca’s COVID-19 vaccine after a study revealed it offered little protection against the deadly disease’s 501Y.V2 variant, which has become dominant in the country. However, it’s unlikely the vaccine will be permanently tossed aside as leaders work to redirect the vaccines elsewhere.